Journal article icon

Journal article

Neuraminidase inhibitors for preventing and treating influenza in children (published trials only)

Abstract:

Background: During epidemics, influenza attack rates in children may exceed 40%. Options for prevention and treatment currently include the neuraminidase inhibitors zanamivir and oseltamivir. Laninamivir octanoate, the prodrug of laninamivir, is currently being developed.
Objectives: To assess the efficacy, safety and tolerability of neuraminidase inhibitors in the treatment and prevention of influenza in children.
Search methods:

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1002/14651858.cd002744.pub4

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Primary Care Health Sciences
Role:
Author
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Primary Care Health Sciences
Role:
Author
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Primary Care Health Sciences
Oxford college:
St Hugh's College
Role:
Author
ORCID:
0000-0003-2418-2091
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Primary Care Health Sciences
Oxford college:
Kellogg College
Role:
Author
Publisher:
Wiley Publisher's website
Journal:
Cochrane Database of Systematic Reviews Journal website
Volume:
7
Issue:
4
Pages:
CD002744
Publication date:
2012-04-18
DOI:
EISSN:
1469-493X
Pmid:
22513907
Source identifiers:
325206
Language:
English
Keywords:
Pubs id:
pubs:325206
UUID:
uuid:59c83c7d-3dfe-41e0-9f56-76567a2df022
Local pid:
pubs:325206
Deposit date:
2018-03-14

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP